Back to Search Start Over

SARS-CoV-2: One Year in the Pandemic. What Have We Learned, the New Vaccine Era and the Threat of SARS-CoV-2 Variants.

Authors :
Scialo, Filippo
Vitale, Maria
Daniele, Aurora
Nigro, Ersilia
Perrotta, Fabio
Gelzo, Monica
Iadevaia, Carlo
Cerqua, Francesco Saverio
Costigliola, Adriano
Allocca, Valentino
Amato, Felice
Pastore, Lucio
Castaldo, Giuseppe
Bianco, Andrea
Source :
Biomedicines; Jun2021, Vol. 9 Issue 6, p611-611, 1p
Publication Year :
2021

Abstract

Since the beginning of 2020, the new pandemic caused by SARS-CoV-2 and named coronavirus disease 19 (COVID 19) has changed our socio-economic life. In just a few months, SARS-CoV-2 was able to spread worldwide at an unprecedented speed, causing hundreds of thousands of deaths, especially among the weakest part of the population. Indeed, especially at the beginning of this pandemic, many reports highlighted how people, suffering from other pathologies, such as hypertension, cardiovascular diseases, and diabetes, are more at risk of severe outcomes if infected. Although this pandemic has put the entire academic world to the test, it has also been a year of intense research and many important contributions have advanced our understanding of SARS-CoV-2 origin, its molecular structure and its mechanism of infection. Unfortunately, despite this great effort, we are still a long way from fully understanding how SARS-CoV-2 dysregulates organismal physiology and whether the current vaccines will be able to protect us from possible future pandemics. Here, we discuss the knowledge we have gained during this year and which questions future research should address. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
22279059
Volume :
9
Issue :
6
Database :
Complementary Index
Journal :
Biomedicines
Publication Type :
Academic Journal
Accession number :
151083231
Full Text :
https://doi.org/10.3390/biomedicines9060611